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Mutations in the transactive response DNA binding protein-43 (TARDBP/TDP-43) gene, which regulates tran-
scription and splicing, causes a familial form of amyotrophic lateral sclerosis (ALS). Here, we characterize
and report the first tardbp mutation in zebrafish, which introduces a premature stop codon (Y220X), elimin-
ating expression of the Tardbp protein. Another TARDBP ortholog, tardbpl, in zebrafish is shown to encode a
Tardbp-like protein which is truncated compared with Tardbp itself and lacks part of the C-terminal glycine-
rich domain (GRD). Here, we show that tardbp mutation leads to the generation of a novel tardbpl splice form
(tardbpl-FL) capable of making a full-length Tardbp protein (Tardbpl-FL), which compensates for the loss of
Tardbp. This finding provides a novel in vivo model to study TDP-43-mediated splicing regulation.
Additionally, we show that elimination of both zebrafish TARDBP orthologs results in a severe motor pheno-
type with shortened motor axons, locomotion defects and death at around 10 days post fertilization.
The Tardbp/Tardbpl knockout model generated in this study provides an excellent in vivo system to study
the role of the functional loss of Tardbp and its involvement in ALS pathogenesis.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative
condition in which death of motor neurons results in progres-
sive failure of the neuromuscular system and death, usually
within 2 to 3 years of symptom onset. About 5–10% of
ALS cases are familial (fALS) and usually of autosomal dom-
inant inheritance, while 90–95% are sporadic in origin (sALS)
(1). Mutations in the transactive response DNA-binding
protein-43 (TARDBP/TDP-43) gene, (ALS10), that encodes
a 43 kDa protein TDP-43, account for 1% of sALS and
3% of fALS cases (2). TDP-43 is a major constituent of the
neurocytoplasmic inclusions (NCIs) present in pathologically
affected regions of ALS and frontotemporal lobar degener-
ation (FTLD) cases (3). The discovery of 38 mutations in
TARDBP associated with ALS and FTLD has established the
importance of this gene in neurodegeneration (4). It is still
debated whether the pathophysiological mechanism related
to TDP-43-associated ALS is due to the loss of the normal
nuclear function or a toxic gain of cytoplasmic function of
TDP-43, or both. Although several in vivo and in vitro
studies have attempted to model the effects of TARDBP muta-
tions, the function and regulation of TDP-43 and the patho-
logical consequences of mutant TDP-43 (mTDP-43) remain
incompletely characterized (5).
TDP-43 is a predominantly nuclear protein, with several
RNA processing functions including roles in the regulation
of transcription, alternative splicing, translation and micro
RNA biogenesis (6,7). Mislocalization of TDP-43 to the cyto-
plasm could result in a loss of its normal RNA processing roles
in the nucleus (8). Drosophila partially lacking TDP-43 are
reported viable and have normal morphology, but exhibit
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abnormal locomotive behavior and defective neuromuscular
junctions (9). Complete knockdown, however, results in le-
thality at the second instar stage (10,11). Furthermore, knock-
out of Tardbp in mice causes early lethality around the
blastocyst implantation stage of embryogenesis (12,13), com-
plicating analysis of its role in vertebrate neural development
and function.
Zebrafish have several key advantages as a vertebrate model
organism. Their external development and optical transpar-
ency allow high-resolution imaging of all developmental
stages and their high fecundity and relatively low maintenance
costs facilitate genetic manipulation and high-throughput
pharmacological screening for disease modifying agents
(14). Several neurodegenerative diseases have been modeled
in the zebrafish, although most of these models do not
mimic the late-onset neurodegeneration phenotype seen in
humans (15). However, the recent development of a zebrafish
mutant sod1 model of ALS mimics several aspects of the adult
onset neurodegenerative disease observed in humans and
transgenic murine models (16).
Two zebrafish orthologs of TARDBP, tardbp (chromosome
6) and tardbp-like (tardbpl)(chromosome 23), have been
described. In contrast to tardbp, zebrafish tardbpl is predicted
to encode a truncated protein Tardbpl (303 amino acids),
lacking most of the C-terminal region of the corresponding
full-length 412 amino acid protein encoded by tardbp.
Transient over-expression of mutant tardbp and morpholino-
mediated knockdown of tardbp have been recently performed
in zebrafish (17,18). A report by Kabashi et al. showed that
while transient translation knockdown using an antisense mor-
pholino oligonucleotide (AMO) of tardbp produced shortening
and disorganization of motor neuron axons and reduced coiling
ability (18), knockdown of tardbpl produced no obvious
defects. The inherent limitations of the AMO technique such
as its transient effects, as well as the potential for off-target
interactions (19), preclude a full understanding of the role of
Tardbp in adult onset neurodegeneration.
We therefore aimed to generate a stable Tardbp deficiency
model by TILLING (Targeted Induced Local Lesions in
Genome). We identified a tardbp null mutant allele with a
base substitution that generates a premature stop codon. Ana-
lysis of this mutant reveals that a loss of the Tardbp protein
results in the upregulation of a novel transcript (tardbpl-FL)
from the tardbpl gene locus by alternative splicing. We
further demonstrate that this full-length tardbpl-FL transcript
can compensate for the loss of Tardbp.
The tardbp/tardbpl-FL double knockout zebrafish that we
have generated provides a new model to study mechanisms
of splicing regulation by Tardbp and of motor neuron injury
caused by loss of function of TDP-43. This new zebrafish
model may also be valuable in identifying targets for thera-
peutic manipulation.
RESULTS
Zebrafish homozygous for a tardbp null mutation
are adult viable
Using TILLING, we identified an ENU-induced allele of tardbp
(tardbpfh301) that has a single nucleotide change c.660C.T
resulting in a premature stop codon (TAC  TAA), p.Y220X
(Fig. 1A) which truncates the 413 amino acids protein midway
through its second RNA binding domain (Fig. 1B). Protein par-
ameter prediction software (http://web.expasy.org/cgi-bin/p
rotparam/protparam) predicts a molecular weight of the prema-
ture truncated protein at 24 kDa and also predicts it to be un-
stable (instability index 50.83). The mutation also causes a loss
of a CViQI restriction enzyme site, which facilitates genotyping
(Fig. 1C). Heterozygous tardbpfh301/+animals were indistin-
guishable from their wild-type (WT) siblings. After repeated
out-crossing, (F6) tardbpfh301/+ heterozygotes were selected
and in-crossed to generate homozygous tardbp mutants
(tardbpfh301/fh301). Interestingly, the expected Mendelian ratios
for a heterozygous (tardbpfh301/+) in-cross were observed at 3
months, indicating that the homozygous (tardbpfh301/fh301) fish
survived at the same rate as the tardbp+/+ and tardbpfh301/+ sib-
lings. The mean weights and standard length (Fig. 1D) of each
adult F5 zebrafish were recorded at the time of fin clipping for
genotyping. tardbpfh301/fh301 zebrafish were lighter in weight
(P , 0.0001) (Fig. 1E) and shorter in length (P , 0.0001)
(Fig. 1F) when compared with tardbp+/+ siblings. To analyze
protein expression, we dissected tissues from three 6-month
old tardbpfh301/fh301 and three tardbp+/+ siblings and obtained
whole cell lysates of brain, eyes, muscle, heart, gills and liver
for immunoblotting using the antibody h.TDP-43 Ab2 (which
recognizes the C-terminus that is conserved between the
human TDP-43 and zebrafish Tardbp). In WT animals, the full-
length functional form of Tardbp was detected in all tissues
tested including the brain and the eyes (Fig. 1G). In contrast,
Tardbp protein was undetectable in tissue extracts from homo-
zygous tardbpfh301/fh301 animals, indicating that it is full-length
tardbp null mutant. To exclude the presence of a stable truncated
form of the Tardbp protein, we also immunoblotted these
samples with an N-terminus Tardbp antibody (h.TDP-43 Ab1)
that is raised against the N-terminal 260 amino acids of
TDP-43. No bands in the predicted 24 kDa region were observed
in the tardbp mutants (Fig. 2A), suggesting that the mutant
protein is unstable and likely to be rapidly degraded. Thus, the
tardbpfh301/fh301 zebrafish represents a null mutant.
A full-length isoform of tardbpl (tardbpl-FL)
is up-regulated in tardbp mutant zebrafish
It has been reported that loss of TDP-43 causes early embry-
onic lethality in mouse and significant motor deficits in
Drosophila (20,21). It was therefore surprising that our homo-
zygous mutant tardbp animals survived until adulthood with
apparently preserved motor function. When we examined the
immunoblot of tardbpfh301/fh301 adult zebrafish with the anti-
body h.TDP-43 Ab1, we surprisingly observed a 20-fold in-
crease in the 43 kDa signal (Fig. 2A, #, and B, $, C, D) in
the tardbpfh301/fh301 fish, instead of the anticipated absence
of the 43 kDa band corresponding to the full-length
Tardbp protein. Since the loss of Tardbp expression has
been observed using the h.TDP-43 Ab2 and since zebrafish
has only two TDP-43 homologs, we hypothesized that the
enhanced 43 kDa signal in tardbpfh301/fh301 lysates might
represent a novel isoform transcribed from the tardbpl locus.
Analysis of the tardbpl locus using the GeneScan software
(GeneScan, MIT) predicted a novel transcript that produces
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an almost full-length Tardbp-like (398 amino acids) protein,
which we have named as Tardbpl-FL. The novel tardbpl-FL
transcript and tardbpl share the same translation initiation site.
Earlier, Kabashi et al. had shown using the AMO method
that knockdown of Tardbpl does not lead to an aberrant pheno-
type and interpreted this to indicate that the tardbpl gene is non-
functional (18). Our own studies with AMO targeted to the
translation initiation site of tardbpl (tardbpl AMO) showed
that injection of even high doses of tardbpl AMO into WT
embryos produced no phenotype and the embryos were macro-
scopically normal at 32 (Fig. 3A–D), 36 and 120 hpf (Supple-
mentary Material, Fig.S2A and C, upper panel). Quantitation of
defects in motor axon development also showed that motor
axons in tardbpl AMO injected WT embryos were normal
and indistinguishable from control AMO (CoMo) injected
embryos (Supplementary Material, Fig. S2B).
Figure 1. The tardbp fh301 mutant (tardbpfh301/+) zebrafish generated by a TILLING process is viable. (A) Through mutation screening of a zebrafish ENU
mutagenesis library, a c.660 C.A missense in-frame mutation in tardbp was detected. (B) The c.660 C.A mutation results in a premature truncation mutation
at the 220 amino acids residue (Threonine) in the RRM2 domain. (C) c.660 C.A also results in a loss of CViQ1 restriction digest enzyme site, which helps to
identify the genotype of the zebrafish following fin clipping. (D) Diagrammatic representation of the measurement of SL of zebrafish at 6 months of age. (E) Fry
from a tardbpfh301/+heterozygous in cross at F5 generation were fin clipped at 6 months of age to identify the genotype. The weights were significantly different
between tardbp+/+ and tardbpfh301/fh301 (230 mg, SD+39 versus 183 mg, SD+40, P , 0.0001) and tardbpfh301/+ (215 mg, SD+46, P , 0.001). There was
no significant weight difference between tardbpfh301/+and tardbp+/+ (P . 0.05). (F) Measurement of the SL revealed significant differences between tardbp+/+
(23.81 mm, SD+1.76), tardbpfh301/+ (22.83 mm, SD+1.26) and tardbpfh301/fh301 (21.67 mm, SD+1.84)(∗P , 0.01, ∗∗P , 0.001, ∗∗∗P , 0.0001). (G) An
immunoblot probed with h.TDP-43 Ab2 (which binds to the C-terminus of TDP-43) demonstrates a loss of Tardbp from all tissues in a 6-month-old adult homo-
zygous mutant zebrafish (tardbpfh301/fh301). h.TDP-43 Ab2 is specific to Tardbp and does not detect Tardbpl.
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To investigate whether this novel tardbpl-FL transcript
from the tardbpl locus is rescuing the tardbp mutant
(tardbpfh301/fh301), we knocked down the expression of the
novel isoform in tardbpfh301/fh301(homozygous) embryos by
injecting a tardbpl AMO. Protein homogenates extracted
from the tardbpfh301/fh301 and WT embryos (tardbp+/+
sibling in-cross) microinjected with tardbpl AMO at 36 hpf
were probed with h.TDP-43 Ab1. Near complete (with 5 ng
of tardbpl AMO) and complete (with 16 ng of tardbpl AMO)
knockdown of the 43 kDa signal (Tardbp-FL novel
protein) was observed in the tardbpfh301/fh301 embryos com-
pared with the control AMO (CoMo) injected and the unin-
jected groups (P, 0.0001) (Fig. 2B $, 2C and D). However,
no change in the 43 kDa band (representing the Tardbp
protein) was observed in tardbpl AMO injected WT embryos
(Fig. 2B). These findings indicate that the 43 kDa protein
form is specifically upregulated in the tardbpfh301/fh301mutant
embryos and is encoded by the tardbpl-FL transcript. The re-
duction of the 33 kDa Tardbpl band in both tardbpfh301/fh301
and WT embryos, following tardbpl AMO injection
(Fig. 2B, ¥), indicates that the zebrafish tardbpl locus can
encode protein isoforms of two differing lengths, the short
(33 kDa) Tardbpl and the full-length (43 KDa) Tardbpl-FL
protein.
tardbp and tardbpl-FL double knockouts have reduced
survival and develop motor defects
Earlier, we saw that knockdown of Tardbpl in WT embryos
produced no phenotype, indicating that the truncated 33 kDa
Tardbpl protein is probably non-functional. However, com-
plete knockdown of Tardbpl-FL using 16 ng of tardbpl AMO
(Fig. 2B $, 2C and D) in tardbpfh301/fh301 embryos resulted
in morphological abnormalities (a curly tail phenotype) as
early as 32 hpf (P , 0.0001) (Fig. 3H and I), whereas 5 ng
of tardbpl AMO produced a less severe phenotype (P ,
0.0001) (Fig. 3G and I). This phenotype progressively wor-
sened over time (Supplementary Material, Fig. S2C). Com-
plete knockdown of Tardbpl-FL in the tardbpfh301/fh301
embryos resulted in significantly reduced survival (all double
morphant/mutant embryos died by 10 dpf) (P, 0.0001) com-
pared with those injected with control AMO (CoMo) (Fig. 3J).
Figure 2. The tardbpfh301/fh301 null phenotype is rescued by over-expression of a tardbpl full-length protein (Tardbpl-FL). (A) Western blot of tissues from
6-month-old adult tardbpfh301/fh301 zebrafish using h.TDP-43 Ab1 which binds to the N-terminus of TDP-43. Compared with the tardbp+/+, tardbpfh301/fh301
embryos have an over expressed signal at 43 kDa molecular weight indicated by $. This relative over-expression of a protein similar to the molecular
weight of Tardbp is present in all the tested tissues of tardbpfh301/fh301 adult zebrafish. (B) tardbpl AMO injection into tardbpfh301/fh301 fish resulted in near com-
plete (5 ng) and complete (16 ng) knockdown of Tardbpl-FL over expression, and Tardbpl (33 kDa, indicated by ¥) suggesting that tardbpl and tardbpl-FL
share a similar translational initiating region. (C) Tardbpl-FL protein is upregulated 20-fold in the tardbpfh301/fh301compared with the tardbp+/+(P , 0.001).
(D) Tardbpl-FL and Tardbpl are knocked down by tardbpl AMO injection in tardbpfh301/fh301 embryos (P , 0.0001).
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The animals injected with the lower dose (5 ng tardbpl AMO)
survived slightly longer but had to be sacrificed when they
showed an inability to swim or feed (Fig. 3J). The double
mutants also had a significantly reduced escape response
(P, 0.0001), demonstrating a motor behavioral defect
caused by loss of both Tardbp and Tardbpl-FL (Fig. 3K).
Simultaneous loss of Tardbp and Tardbpl-FL results
in significant axonal path finding defects
It is well established that mutations in the human TARDBP gene
are associated with ALS and are, therefore, deleterious to motor
neurons. However, there was no significant difference in the
motor axonal morphology between tardbpfh301/fh301 and WT
control fish at 36 hpf (Fig. 4A–C) and the control AMO
(CoMo) injected groups (Fig. 4D–F). Additionally, motor
axon development was completely normal in WT embryos
injected with tardbpl AMO (Fig. 4 G, J and M and Supplemen-
tary Material, Fig. S2B). We therefore analyzed the effects of
loss of both Tardbp and Tardbpl-FL on motor axons of the
tardbp mutant. Knockdown of Tardbpl-FL with 16 ng tardbpl
AMO in tardbpfh301/fh301 embryos resulted in a complete arrest
of axonal outgrowth at 36 hpf (P, 0.0001) (Fig. 4K, L and
N). A less severe axonal path finding defect was observed
with a lower dose (5 ng, P , 0.001) of tardbpl AMO (Fig. 4H
and I). Taken together, these findings confirm that tardbpl-FL
is able to compensate for the loss of tardbp. Expression of
Tardbpl-FL in tardbpfh301/fh301 mutants showed that this novel
transcript is expressed right from the earliest stages of develop-
ment, indicating that it may be stored maternally in the oocyte,
with continued endogenous expression during development
(Supplementary Material, Fig. S3).
tardbpl-FL is a novel alternatively spliced tardbpl
transcript
The basal level of Tardbpl (33 kDa isoform) is higher in WT
zebrafish compared with tardbpfh301/fh301 zebrafish (Fig. 2C, ¥
and 5A,∗). The reduced level of Tardbpl in the mutant may
correlate with the compensatory upregulation of Tardbpl-FL
(43 kDa isoform). We postulated that alternative splicing of
tardbpl could generate the two forms (Fig. 5B and C). Follow-
ing alignment of exon–intron boundaries of the GeneScan
predicted tardbpl transcript with the exons and introns of
tardbpl, we determined that the novel transcript could be gen-
erated by alternative splicing. Both splice isoforms share nu-
cleotide identity at the translation initiation site, consistent
with the finding that the tardbpl AMO knocks down both
Figure 3. Effects of Tardbpl-FL knockdown in WT and tardbp null zebrafish embryos. (A–D) Uninjected, control AMO (CoMo) injected and tardbpl AMO with
p53 (tardbpl AMO +p53) groups of WT (tardbp+/+) embryos were morphologically normal when compared with tardbpl AMO with p53 injected HOM
(tardbpfh301 /fh301 embryos) zebrafish (E–H) which develop a curly tail phenotype at 32 hpf (P , 0.0001) (I). (J) Knockout of Tardbp and Tardbpl/Tardbpl-FL
significantly reduces survival of tardbpfh301/fh301 embryos to 10 dpf (16 ng) and 16 dpf (5 ng) and both Kaplan–Meier curves are statistically significant com-
pared with the control AMO (COMO)+p53 injected group (P , 0.001). (K) The double knockout zebrafish also had a significantly reduced escape response
(P, 0.0001), demonstrating a motor behavioral defect caused by loss of both Tardbp and Tardbpl-FL.
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Tardbpl and Tardbpl-FL (Fig. 2B, $ and ¥). We performed
qRT–PCR, using transcript-specific primers designed across
exon–exon boundaries, to quantify the relative abundance of
the two splice isoforms, tardbpl and tardbpl-FL. An internal
primer set was designed to cross the exon 2–3 boundaries in
the 5′′ end of the gene, which is common to both tardbpl
and tardbpl-FL. Complementary DNA (cDNA) amplified
using the RNA extracted from both tardbp+/+ (WT) and
tardbpfh301/fh301 (HOM) embryos showed that in the
tardbpfh301/fh301 embryos, tardbpl-FL is over-expressed by as
much as 2.4-fold (DD CT, WT-HOM tardbpfh301/fh301
+1.27), while tardbpl expression is reduced by 0.8-fold
(DD CT, WT-HOM tardbpfh301/fh301 20.21)(Fig. 5D) (Sup-
plementary Material, Fig. S4). These data confirm that
tardbpl is indeed alternatively spliced to generate the newly
identified tardbpl-FL transcript.
DISCUSSION
TDP-43 is one of the key proteins involved in the pathogenesis
of FTLD-U and ALS (22). The importance of TDP-43-related
Figure 4. Motor axons are abnormal in Tardbpl-FL knocked down tardbpfh301/fh301embryos at 36 hpf. Lateral views of the whole-mounted tardbp+/+and
tardbpfh301/fh301embryos stained with znp-1 to detect axons. (A–C) Uninjected tardbp+/+(WT) and tardbpfh301/fh301 do not show any significant difference in
axonal defects similar to control AMO (CoMo) injected groups (D–F). (G–I) Partial knockdown of Tardbpl-FL with tardbpl AMO +p53 results in a significant
rise in the axonal defects in the tardbpfh301/fh301mutant zebrafish (P , 0.001). (J) Normal motor axons in tardbp+/+injected with tardbpl AMO 16 ng. (K) Com-
plete knockdown of tardbpl-FL in the tardbpfh301/fh301resulted in severe axonal outgrowth defects with complete arrest of axons at the horizontal myoseptum
(P , 0.0001) (L). (M and N) Enlarged sections of (J and K) demonstrating severe axonal out growth defects in the double knockout (Tardbp and Tardbl-FL)
embryos. Black arrow points out at an infrequent axonal truncation defect (low dose tardbpl AMO), while white arrows indicate numerous axonal out growth
defects (high dose tardbpl AMO).
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pathology in ALS and FTLD-U has been reinforced by the
recent discovery, showing that TDP-43 pathology predomi-
nates in ALS and FTLD cases with an intronic hexanucleotide
repeat expansion in C9ORF72, which accounts for up to 50%
of fALS and 7–10% of sALS cases (23–25). Aggregate for-
mation with C-terminus truncated, hyperphosphorylated
TDP-43 and a dramatic redistribution of nuclear TDP-43 to
the cytoplasm of surviving motor neurons in pathological
samples have been consistently observed (3). This reduction
of normal nuclear expression of TDP-43 may affect vital
nuclear functions such as transcription and post-transcriptional
regulation of gene expression, including alternative splicing
(26). Therefore a strong case exists to investigate the
loss of function as a potential mechanism of TDP-43-related
pathology.
Here, we describe the first stable mutant TDP-43 (tardbp)
zebrafish model of ALS by TILLING. The loss of TDP-43 has
been shown to cause embryonic lethality in mice (20) and fruit-
fly (10). Additionally, Kabashi et al. showed that morpholino-
mediated transient knockdown of Tardbp was shown to
produce a severe impairment of motor axon growth and devel-
opment (18). Thus, it was surprising to observe normal Mendel-
ian ratios maintained among homozygous (tardbpfh301/fh301),
heterozygous (tardbpfh301/+) and WT (tardbp+/+) zebrafish
generated from a heterozygous (tardbpfh301/+) in cross, and
survival of homozygous mutant (tardbpfh301/fh301) animals to
adulthood. To ensure that earlier morpholino studies reproduced
in our hands, we used identical morpholinos to that used in the
Kabashi study, and we also observed that AMO knockdown of
Tardbp using the translation blocking AMO produced severely
defective embryos when injected in both WT and the
tardbpfh301 mutants (Supplementary Material, Fig. S5E and
F). However, even when we used the highest dose of a splice
blocking AMO, which completely eliminated the WT splice
form of Tardbp (Supplementary Material, Fig. S5B), we saw
that the embryos were apparently normal (Supplementary
Figure 5. Alternative splicing of tardbpl gives rise to tardbpl-FL, which rescues the tardbpfh301/fh301 null phenotype. (A)Western blot of WT and tardbpfh301/fh301
embryos at 48 hpf, probed with h.TDP-43 Ab1, demonstrating relative over expression of Tardbpl-FL (solid black arrow) and the reduction in Tardbpl expression
in the tardbpfh301/fh301 mutant zebrafish (asterisk). (B) Introns 5–6 of the tardbpl (ENSDART00000027255) on chromosome 23 contain a coding sequence,
which potentially could give rise to a longer Tardbpl protein (Tardbpl-FL). (C) Predicted alternative splicing event, which results in inclusion of introns
5–6 creating tardbpl-FL. RT–PCR primers for common exon (exons 2 and 3), tardbpl-FL-specific primers (exons 4 and 5 but within intron 6 of tardbpl)
and tardbpl-specific primer (exons 4 and 7) are also shown by arrows. (D) qRT–PCR estimation of expression of tardbpl and tardbpl-FL revealed a
2.42-fold increase (tardbpl-FL, DDCT WT-tardbpfh301/fh301 of +1.27) in the tardbpl-FL expression in tardbpfh301/fh301mutant embryos compared with the WT
embryos at 48 hpf and tardbpl expression was reduced in the tardbpfh301/fh301mutant embryos (tardbpl,DDCT WT-tardbpfh301/fh301 of20.213). (E) ClustalW2 align-
ment of the Tardbp and predicted Tardbpl-FL amino acid sequences. Both the N and the C termini are highly conserved. Tardbpl-FL is missing nine amino acids from
the GRD, of which six are glycine residues (highlighted in grey).
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Material, Fig. S5G and H). Thus, we believe that the translation
blocking AMO experiments may have some off-target mediated
effects that could have contributed to the observed phenotype.
Although morpholino (AMO)-based approaches have in
general been useful for the characterization of gene function,
here we present a scenario where generation of a stable
mutant but not the AMO approach was useful in identifying
the function of a duplicated gene. This highlights one potential
pitfall of using purely morpholino-based approaches to study
gene function and indicates that a combined approach may
add value in some circumstances.
The upregulation of a novel isoform from the tardbpl locus
shown in our studies supports the idea that compensation by
the tardbpl locus in the tardbp mutants may explain the viabil-
ity of these mutants. Here, we show that the loss of full-length
Tardbp in the tardbpfh301/fh301animals leads to enhanced alter-
native splicing of tardbpl to generate a novel transcript
tardbpl-FL, indicating the existence of a newly identified
regulatory loop that controls Tardbp levels in zebrafish. In
addition, we demonstrate that knockdown of both Tardbp
and Tardbpl-FL leads to severe defects in motor neuronal de-
velopment, therefore establishing a vital role for Tardbp in
motor neuron and axon development. Studies in vitro have
shown that TDP-43 knockdown in a neuronal cell line using
small interfering RNA (siRNA) resulted in neurite out
growth defects and increased cell death (27). Abnormal axo-
nogenesis has also been observed in a variety of zebrafish
models of motor neuron disease and in sod1 mouse models
of ALS (28–30). Axonal changes are reflected much earlier
than motor neuron loss in ALS and the abnormal axonal devel-
opment may reflect some underlying sensitivity of motor
axons to these mutations. This provides a novel, tractable ver-
tebrate model for the analysis of the physiological conse-
quences of the loss of Tardbp in a small vertebrate model
that is amenable for studying disease processes in vivo at
single neuron resolution and for high throughput drug and
genetic screens.
It is noteworthy that humans also have two TARDBP genes;
one is located on chromosome 1p36.22 (TARDBP) while the
other is a pseudogene located on chromosome 20p12.3
(TARDBPP1). The tardbp gene in zebrafish is located on
chromosome 6 and the tardbpl gene is located on chromosome
23. Zebrafish and humans appear to share ancestral chromo-
somes (31). We compared the synteny map of the tardbp
and tardbpl loci in zebrafish with those of the human and
mouse genes and the pseudogenes, and found partial conserva-
tion of synteny in both cases. However, genes around the zeb-
rafish tardbp locus were less rearranged compared to those at
the tardbpl locus (Supplementary Material, Fig. S6). The zeb-
rafish chromosome 23 is extensively recombined and relevant
genes are distributed amongst many other chromosomes in
humans (such as 1,2,6,12,20 and X), with a component on
chromosome 20, where the human TARDBPP1 gene is
located. Similarly in the mouse, near the syntenic region of
human chromosome 20 (mouse chromosome 2), we are able
to locate a Tardbp pseudogene (GM13886). Thus, it is likely
that ‘tardbpl’ in humans and mice underwent recombination
events that could have potentially led to the loss of functional
tardbpl and the creation of the TARDBPP1 pseudogene and
GM13886 respectively.
It is of interest to question what selection pressure enabled the
maintenance of functional tardbp and tardbp-FL genes in zebra-
fish. One interesting clue suggesting divergent roles for Tardbp and
Tardbpl-FL is the phenotype of the tardbpfh301/fh301 mutants. We
observed that despite the upregulation of tardbpl-FL in the
tardbpfh301/fh301 mutant zebrafish, the mutants were smaller in
size compared with WT (Fig. 1), which indicates that tardbp
and tardbpl may have both functionally overlapping and distinct
roles in zebrafish development and in adult life. The small
body phenotype of tardbpfh301/fh301 animals suggests that
tardbp may play a critical role in growth regulation, which is
not fully compensated by the upregulation of tardbpl-FL expres-
sion in the mutants. In keeping with this are the findings from con-
ditional postnatal knockout of Tardbp in mice which showed that
these mice develop loss of body weight and down regulation of
Tbc1d1, increased expression of which is associated with
obesity (32). Thus, the specialized role played by tardbp when
compared with tardbpl may have been important in maintaining
the two genes during evolution. As we do not yet have a stable
tardbpl mutant, we do not yet know what specific role tardbpl-FL
may play in zebrafish development.
Upregulation of Tardbpl-FL expression by alternative spli-
cing of the tardbpl locus in the tardbpfh301/fh301 mutants is
interesting. It was recently shown that autoregulation of
TARDBP involved a 3′′UTR TARDBP binding site that
under high TARDBP conditions led to increased intron 6 spli-
cing and RNA polymerase stalling resulting in a shorter
TARDBP ORF, V2 TARDBP transcript that is degraded by a
nonsense-mediated decay. Under conditions of low
TARDBP expression, this mechanism occurs at a low effi-
ciency, thus promoting the stable longer V1pA4 and V1pA1
TARDBP transcript which makes the full-length protein
(33,34). The generation of the tardbpl-FL transcript occurs
by the inclusion of intron 5 of tardbpl, which is able to code
for the additional C-terminal amino acids generating an
almost full-length Tardbp-like protein and exclusion of
exons 6 and 7. Intron 5 contains a UGUGU motif near the
splice donor site of exon 6. Additionally, another canonical
high affinity TDP-43 binding site –(GU)6 is located in
intron 6 which is the 3′UTR region of the tardbpl-FL tran-
script. Although the UGUGU motif is not a canonical high af-
finity RNA binding site of TDP-43, it has the elements
required for interacting with TDP-43 during splicing (35). A
loss of Tardbp (condition of low Tardbp expression) could po-
tentially regulate the tardbpl/tardbpl-FL splicing process, by
allowing intron 5 inclusion, and eliminating intron 6 splicing,
thus producing the tardbpl-FL transcript. Taken together,
these results predict an in vivo auto-regulatory model involv-
ing tardbp and tardbpl/tardbpl-FL in keeping with the type
of auto-regulatory mechanism/s hypothesized for
TDP-43(33,34). Although this alternative splicing of tardbpl
is zebrafish specific, it provides a good model system to
study differential splicing by tardbp.
One interesting aspect of the upregulation of Tardbpl-FL
expression is that it is unable to completely rescue the loss
of Tardbp. Tardbpl-FL lacks nine residues from the
glycine-rich domain (GRD) of which six are glycine residues.
Two interesting observations in this model over-expressing
tardbpl-FL are evident. First, despite the high homology
between Tardbpl-FL and Tardbp, Tardbpl-FL is unable
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to auto-regulate itself, resulting in a massive 20-fold upregula-
tion of the Tardbpl-FL protein. Second, an observation from
TDP-43 over expression in vitro and in vivo models is that
over-expression of full-length WT, mutant TDP-43 or C ter-
minal fragments of TDP-43 are all toxic and/or lethal
(17,36). The toxicity of over-expression of exogenous
TDP-43 even at relatively low levels in transgenic rodents
(37,38) is not observed in the tardbpfh301/fh301 null zebrafish
with compensatory 20-fold increase in the Tardbpl-FL
protein level. Therefore, it is plausible that the glycine resi-
dues which are missing from the GRD of the Tardbpl-FL
(Fig. 5E shaded in grey) are indeed important for efficient
tardbp slicing and potentially for mediating the toxicity
of tardbp.
Taken together, our data describe for the first time, a critical
role for tardbp and tardbpl in zebrafish development. We
show that tardbp is important in the regulation of body size
as over-expression of Tardbpl-FL in the tardbpfh301/fh301
mutants is unable to rectify this deficit. However, increased
tardbp-FL expression in tardbpfh301/fh301 mutants is able to
partially compensate for the early developmental role of
tardbp. The complete knockdown of tardbp and tardbpl-FL
results in severely abnormal motor neuronal development
and concurrent embryonic lethality, demonstrating a critical
role for Tardbp or Tardbpl-FL in embryonic neurodevelop-
ment. The uncovering of a newly identified regulatory loop
between tardbp and tardbpl and the discovery of tardbpl-FL
in zebrafish will allow us to use the double knockdown zebra-
fish model to study disease mechanisms and neuroprotective
strategies and to better understand human ALS associated
with TARDBP mutations.
MATERIALS AND METHODS
Zebrafish husbandry
Adult zebrafish and embryos were raised at 28.58C. WT
animals were from the AB strain. Embryo collections, AMO
(antisense morpholino oligonucleotide) microinjection and
maintenance of the mutant and WT zebrafish lines were
carried out according to the standard protocols and in accord-
ance with UK Animals (Scientific Procedures) Act 1986. The
tardbpY220X, mutant (tardbpfh301) line was generated using
the TILLING process undertaken in the Fred Hutchinson
Cancer Research Center, Seattle, USA, under Animal Care
protocol 1342, which is reviewed and approved annually by
the FHCRC Institutional Animal Care and Use Committee
and is in accordance with the recommendations of the Ameri-
can Veterinary Association.
Generation of a tardbp nonsense allele (tardbpfh301)
The tardbpfh301 mutant was generated in the AB background
and identified in a TILLING screen. The mutant was recov-
ered by in vitro fertilization of AB eggs using a cryo-preserved
sperm sample from a single heterozygous F1 male. Heterozy-
gous F1 adults were out-crossed into the AB background and
heterozygous F2 adult fish identified by fin clipping and geno-
typing. The F2 heterozygous (tardbpfh301/+) animals were bred
with AB fish for three further generations to obtain F5 mutant
heterozygotes. All experiments were carried out on F6
progeny homozygous for the c.660 C.A (tardbpfh301/fh301)
and their WT (tardbp+/+) siblings.
Fin clipping, genotyping by PCR and measurement
of weight and length of adult zebrafish
Adult zebrafish at 3 months were fin clipped to identify the
genotype as previously described (39). At the same time,
anesthetized fish were weighed and measured from the tip of
the lower jaw to the end of the hipural plate. Once the geno-
typing results were available, fish were grouped into tanks
of their respective genotype. DNA was extracted using a
DNAeasy kit (Qiagen). A pair of primers was designed
(tardbp_genFWD 5′CAAGGTATAGATGAACCAATGAGG
A_3′ and tardbp_genREV 5 GTCATCTGCAAAGGTG
ACAAAAG 3′) for PCR amplification of the extracted
DNA. The PCR mixture was digested overnight with CVQI
at 258C. The genotypes were identified based on fragment
sizes after gel electrophoresis. In initial experiments, DNA
extracted and genotyped using CViQI, as above, was also
sequenced to verify the mutation.
Assessment of the swimming of the larvae
Swimming behavior of the larvae at 5 dpf was assessed.
Larvae were probed externally and their escape response
was analyzed. The escape response was classified into
four categories: normal swimming (3), reduced speed (2),
corkscrew movement or minimal movement (1) and no move-
ment (0).
Biochemistry and immunoblotting
Six-month-old homozygous (HOM) (tardbpfh301/fh301) and
WT adult zebrafish (four zebrafish per group) were sacrificed
using 2% Tricaine (Sigma, UK) to obtain brain, spinal cord,
eyes, muscle, heart, gills and liver for protein and RNA ex-
traction. Protein extraction from embryos was carried out at
36 hpf or 48 hpf. At least 100 embryos were collected for
each category studied and deeply anesthetized as for adult
zebrafish with Tricaine. Protein extraction from samples
was carried out as previously described with minor modifica-
tions (16). The membranes were probed with an anti-human
TDP-43 antibody 1 (N-terminal 1–260 amino acids) and
TDP-43 antibody 2 (last 160 amino acids of the C terminus)
(both from Proteintech) which we will refer to as h.TDP-43
Ab1 (1:1200) and h.TDP-43 Ab2 (1:1500), respectively, in
the article. The h.TDP-43 Ab1 is predicted to detect both
the Tardbp and Tardbpl proteins because of the homology
of the N-terminal regions of these proteins, whereas the C-
terminal antibody h.TDP-43 Ab2 will detect Tardbp but
not Tardbpl. Alpha-tubulin expression was used as the
loading control (1:10,000) (Sigma). Immunoblots were
developed using the ECL detection kit (GELifesciences.-
com) and the G box hardware and software which were
also used for densitometry (Integrated Scientific Solutions,
San Diego, CA, USA).
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Antisense morpholino oligonucleotide (AMO) mediated
knockdown of tardbpl
A translation-blocking AMO was designed to knockdown
tardbpl (tardbpl AMO) (5′-CCACACGAATATAGCACTCC
GTCAT-3′). The standard control AMO (CoMo) (Genetools,
LLC, Philomath, OR, US A) was also used to distinguish
the specificity of the effects seen from the knockdown of
tardbpl. Furthermore an AMO against zebrafish tumor sup-
pressor p53 (p53) gene (p53 AMO) was also used along with
the tardbpl AMO (Genetools). The AMO was dissolved in
nuclease-free sterile water to obtain a stock solution of
4 nmol/ml. The optimal dose was established by injecting a
range of tardbpl AMO concentrations along with 8 ng of
p53 AMO. To monitor the accuracy of injections, phenol red
(Sigma) was added at a final concentration of 1% prior to
injecting the zebrafish embryos. One nanoliter of the optimal
AMO dilution was injected into the yolk sac of the embryos
at the one to two cell stage. Survival of the embryos injected
with tardbpl AMO, control AMO (CoMo) and uninjected con-
trols was monitored for 72 hpf. Embryos were observed at 4,
8, 24, 32–36, 48 and 72 hpf for any obvious morphological
changes. At least four independent experiments were carried
out per injection category and each experimental repeat
included at least 100 embryos per category. Embryos were
then processed as required for immunohistochemistry and im-
munoblotting.
Immunohistochemistry on whole-mount embryos
Immunohistochemistry was carried out on whole-mount
36 hpf embryos as previously described (40). The znp-1
mouse monoclonal antibody (1:400) was used to label motor
axons, and mouse anti-islet-1 to identify neuronal cell bodies
(both from DSHB, University of Iowa, USA). Motor axonal
projection defects were assessed by counting the number of
axons that were either prematurely truncated or abnormally
branched at or just below the horizontal myoseptum. A total
of 10 axons in both hemi-segments of each zebrafish were
counted immediately caudal to the yolk bulge to standardize
the counting across all groups. Each hemi-segment was
scored out of 10 for the number of axons with premature trun-
cating or branching or both defects. At least 30 embryos per
category for each of four experimental repeats were counted.
The number of motor neurons and Rohon Beard neurons
stained with islet-1 were counted across eight myo-segments
from immediately caudal to the yolk bulge to the end of the
yolk extension. Images were obtained using a Zeiss light
microscope with bright field settings. Images were analyzed
using NIH Image J (Rasband, W.S., ImageJ, US National
Institutes of Health, Bethesda, MD, USA, http://imagej.nih.
gov/ij/, 1997–20120) software.
RNA extraction and quantitative real time PCR
(qRT-PCR)
Tissues from adult zebrafish or embryos were obtained as
described earlier and total RNA was extracted using the
Trizol reagent (Invitrogen, UK). One microgram of RNA
was used for the synthesis of first-strand cDNA synthesis.
Gene-specific primers were designed for tardbpl (forward
5′-CGTCACCTTCGCAGACGATCAGGTT-3′ and reverse
5′-GCCTAAGCACAATAATATTCATCACCTCTTTTCCAA
TT-3′, tardbpl-FL (forward 5′-CGTCACCTTCGCAGACG
ATCAGGTT-3′ and reverse 5′-GCCCACGATCCATCATTT
GCCTACTATT-3′). A set of primers, which amplifies a
common sequence within both tardbpl and tardbpl-FL, were
used as an internal control for qRT-PCR (forward 5′ –TCT
GGTGTACGTGGTTAATTATCCAAAAGATAACA-3′ and
the reverse 5′-AGAGGTGATCATGGTGCAGGTGAAAAG).
Two housekeeping genes, which have been well characterized
for use in zebrafish [EF1alpha, forward (5′-CTGGAGGCC
AGCTCAAACAT-3′), reverse (5′-ATCAAGAAGAGTAGT
ACCGCTAGCATTAC-3′) and RP113 alpha, forward (5′-T
CTGGAGGACTGTAAGAGGTATGC-3′), reverse (5′ –AGA
CGCACAATCTTGAGAGCAG-3′)] were used for standardiz-
ing the qRT–PCR results as previously described (41).
Primers were optimized and efficiency assessed by analyzing
the standard curves. A real-time PCR was performed using an
ABI Prism 7900 HT sequence detection system (Applied
Biosystems) using an Evergreen fluorescent label.
Statistical analysis
When three or more groups were compared, one-way
ANOVA, with Kruskal–Wallis statistic and with Dunn’s mul-
tiple comparison testing as appropriate, was used. When only
two groups were compared, a paired t-test was used. The
results of three independent experiments were used in every
analysis.
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